90 related articles for article (PubMed ID: 17709176)
1. Polymorphic variations in exon 10 of the luteinizing hormone receptor: functional consequences and associations with breast cancer.
Piersma D; Verhoef-Post M; Look MP; Uitterlinden AG; Pols HA; Berns EM; Themmen AP
Mol Cell Endocrinol; 2007 Sep; 276(1-2):63-70. PubMed ID: 17709176
[TBL] [Abstract][Full Text] [Related]
2. A common polymorphism renders the luteinizing hormone receptor protein more active by improving signal peptide function and predicts adverse outcome in breast cancer patients.
Piersma D; Berns EM; Verhoef-Post M; Uitterlinden AG; Braakman I; Pols HA; Themmen AP
J Clin Endocrinol Metab; 2006 Apr; 91(4):1470-6. PubMed ID: 16464948
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the KDR and POSTN genes: association with breast cancer susceptibility and prognosis.
Försti A; Jin Q; Altieri A; Johansson R; Wagner K; Enquist K; Grzybowska E; Pamula J; Pekala W; Hallmans G; Lenner P; Hemminki K
Breast Cancer Res Treat; 2007 Jan; 101(1):83-93. PubMed ID: 16807673
[TBL] [Abstract][Full Text] [Related]
4. Single nucleotide polymorphisms in the multidrug resistance gene 1 (ABCB1): effects on its expression and clinicopathological characteristics in breast cancer patients.
Vaclavikova R; Nordgard SH; Alnaes GI; Hubackova M; Kubala E; Kodet R; Mrhalova M; Novotny J; Gut I; Kristensen VN; Soucek P
Pharmacogenet Genomics; 2008 Mar; 18(3):263-73. PubMed ID: 18300948
[TBL] [Abstract][Full Text] [Related]
5. Nested case-control study of energy regulation candidate gene single nucleotide polymorphisms and breast cancer.
Wang Y; McCullough ML; Stevens VL; Rodriguez C; Jacobs EJ; Teras LR; Pavluck AL; Thun MJ; Calle EE
Anticancer Res; 2007; 27(1B):589-93. PubMed ID: 17348446
[TBL] [Abstract][Full Text] [Related]
6. SNPs in ultraconserved elements and familial breast cancer risk.
Yang R; Frank B; Hemminki K; Bartram CR; Wappenschmidt B; Sutter C; Kiechle M; Bugert P; Schmutzler RK; Arnold N; Weber BH; Niederacher D; Meindl A; Burwinkel B
Carcinogenesis; 2008 Feb; 29(2):351-5. PubMed ID: 18174240
[TBL] [Abstract][Full Text] [Related]
7. Associations between androgen and Vitamin D receptor microsatellites and postmenopausal breast cancer.
Wedrén S; Magnusson C; Humphreys K; Melhus H; Kindmark A; Stiger F; Branting M; Persson I; Baron J; Weiderpass E
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1775-83. PubMed ID: 17855696
[TBL] [Abstract][Full Text] [Related]
8. GnRH and LHR gene variants predict adverse outcome in premenopausal breast cancer patients.
Piersma D; Themmen AP; Look MP; Klijn JG; Foekens JA; Uitterlinden AG; Pols HA; Berns EM
Breast Cancer Res; 2007; 9(4):R51. PubMed ID: 17692113
[TBL] [Abstract][Full Text] [Related]
9. Human epithelial growth factor receptor 2[Ile655Val] polymorphism and risk of breast fibroadenoma.
Zubor P; Kajo K; Stanclova A; Szunyogh N; Galo S; Dussan CA; Minarik G; Visnovsky J; Danko J
Eur J Cancer Prev; 2008 Feb; 17(1):33-8. PubMed ID: 18090908
[TBL] [Abstract][Full Text] [Related]
10. Single nucleotide polymorphisms in chromosomal instability genes and risk and clinical outcome of breast cancer: a Swedish prospective case-control study.
Brendle A; Brandt A; Johansson R; Enquist K; Hallmans G; Hemminki K; Lenner P; Försti A
Eur J Cancer; 2009 Feb; 45(3):435-42. PubMed ID: 19008095
[TBL] [Abstract][Full Text] [Related]
11. Endostatin gene variation and protein levels in breast cancer susceptibility and severity.
Balasubramanian SP; Cross SS; Globe J; Cox A; Brown NJ; Reed MW
BMC Cancer; 2007 Jun; 7():107. PubMed ID: 17587451
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker.
Brendle A; Lei H; Brandt A; Johansson R; Enquist K; Henriksson R; Hemminki K; Lenner P; Försti A
Carcinogenesis; 2008 Jul; 29(7):1394-9. PubMed ID: 18550570
[TBL] [Abstract][Full Text] [Related]
13. Intercellular adhesion molecule-1 genetic markers (+241G/A and +469A/G) in Iranian women with breast cancer.
Arandi N; Talei A; Erfani N; Ghaderi A
Cancer Genet Cytogenet; 2008 May; 183(1):9-13. PubMed ID: 18474291
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in the vitamin D receptor gene and risk of lung cancer.
Dogan I; Onen HI; Yurdakul AS; Konac E; Ozturk C; Varol A; Ekmekci A
Med Sci Monit; 2009 Aug; 15(8):BR232-42. PubMed ID: 19644412
[TBL] [Abstract][Full Text] [Related]
15. A functional promoter polymorphism in the TERT gene does not affect inherited susceptibility to breast cancer.
Varadi V; Brendle A; Grzybowska E; Johansson R; Enquist K; Butkiewicz D; Pamula-Pilat J; Pekala W; Hemminki K; Lenner P; Försti A
Cancer Genet Cytogenet; 2009 Apr; 190(2):71-4. PubMed ID: 19380022
[TBL] [Abstract][Full Text] [Related]
16. A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression.
De Feo E; Persiani R; La Greca A; Amore R; Arzani D; Rausei S; D'Ugo D; Magistrelli P; van Duijn CM; Ricciardi G; Boccia S
Mutat Res; 2009 Apr; 675(1-2):60-5. PubMed ID: 19386249
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity.
Willems P; Claes K; Baeyens A; Vandersickel V; Werbrouck J; De Ruyck K; Poppe B; Van den Broecke R; Makar A; Marras E; Perletti G; Thierens H; Vral A
Genes Chromosomes Cancer; 2008 Feb; 47(2):137-48. PubMed ID: 18000863
[TBL] [Abstract][Full Text] [Related]
18. EDN1 Lys198Asn is associated with diabetic retinopathy in type 2 diabetes.
Li H; Louey JW; Choy KW; Liu DT; Chan WM; Chan YM; Fung NS; Fan BJ; Baum L; Chan JC; Lam DS; Pang CP
Mol Vis; 2008 Sep; 14():1698-704. PubMed ID: 18806884
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome.
Valkenburg O; Uitterlinden AG; Piersma D; Hofman A; Themmen AP; de Jong FH; Fauser BC; Laven JS
Hum Reprod; 2009 Aug; 24(8):2014-22. PubMed ID: 19403562
[TBL] [Abstract][Full Text] [Related]
20. Genetic variations associated with the effect of testicular cancer treatment on gonadal hormones.
Aschim EL; Oldenburg J; Kristiansen W; Giwercman A; Witczak O; Fosså SD; Haugen TB
Hum Reprod; 2014 Dec; 29(12):2844-51. PubMed ID: 25336703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
